Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
COLETTE is an interventional study for which blood, cerebrospinal fluid and post-mortem tissues are collected in patients with status epilepticus or epilepsy associated to dysimmune encephalitis as well as in control patients, to better understand the pathophysiology of these severe epileptic disorders.
Eligibility criteria
Qualifiers
Patients aged 2 years or above, with status epilepticus.
Affiliation to a French social security system excluding "Aide Médicale" Etat (AME).
Patients or relatives have been informed and given free informed and written consent to participate
Patients under legal protection (guardianship, curatorship) or not
Disqualifiers
Women with known or clinically detected pregnancy.
Patient deprived of liberty
Patients with known neurodegenerative disease.
Women with known or clinically detected pregnancy.
Trial design
Treatments tested in this trial
- Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3)
- Blood sampling, cerebrospinal fluid, stool sampling post-mortem cerebral tissues (NA for the Group 3)
Treatment groups
400 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov